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IncretinA role for the gastro-intestinal tract in controlling bone remodeling is suspected since serum levels of bone
remodeling markers are affected rapidly after a meal. Glucose-dependent insulinotropic polypeptide (GIP)
represents a suitable candidate in mediating this effect. The aim of the present study was to investigate the
effect of total inhibition of GIP signaling on trabecular bone volume, microarchitecture and quality. We
used GIP receptor (GIPR) knockout mice and investigated trabecular bone volume and microarchitecture
by microCT and histomorphometry. GIPR-deﬁcient animals at 16 weeks of age presented with a signiﬁcant
(20%) increase in trabecular bone mass accompanied by an increase (17%) in trabecular number. In addition, the
number of osteoclasts and bone formation rate was signiﬁcantly reduced and augmented, respectively in these
animals when compared with wild-type littermates. These modiﬁcations of trabecular bone microarchitecture
are linked to a remodeling in the expression pattern of adipokines in the GIPR-deﬁcient mice. On the other
hand, despite signiﬁcant enhancement in bone volume, intrinsic mechanical properties of the bone matrix was
reduced as well as the distribution of bone mineral density and the ratio of mature/immature collagen
cross-links. Taken together, these results indicate an increase in trabecular bone volume in GIPR KO animals
associated with a reduction in bone quality.
© 2012 Elsevier Inc. All rights reserved.Introduction
Bone is a livingmineralizedmaterial, highly complex and constantly
remodeled in mass and architecture to adapt and repair the damages
induce by growth, ageing and mechanical stress. In order to maintain a
constant bone mass, bone remodeling necessitates a spatio-temporal
coupling between osteoclasts, the bone-resorbing cells, and osteoblasts,
the bone-forming cells. Bone remodeling is under a complex regulation
from various factors that may affect osteoclast and osteoblast physiol-
ogies. A role for gastro-intestinal hormones in controlling bone re-
modeling has been suggested as changes in the proﬁle of serum
markers of bone remodeling after a meal coincides with a peak in
gastro-intestinal hormones releases [1,2].
Glucose-dependent insulinotropic polypeptide (GIP) is an important
gastro-intestinal hormone synthesized and secreted into the blood
stream by the duodenal endocrine K cells after ingestion of a mixed
meal [3–5]. To induce a biological response, it binds to glucose-
dependent insulinotropic polypeptide receptors (GIPRs), expressed58, Institut de Biologie en Santé,
, France. Fax: +33 244 688 451.
(G. Mabilleau).
rights reserved.in the endocrine pancreas, gastrointestinal tract, brain, immune
and cardiovascular systems, testis, pituitary, lung, kidney, thyroid,
several regions in the central nervous system and adipose tissue
[6]. Despite a wide distribution of its receptor in the body, the most
remarkable action of GIP is to potentiate glucose-stimulated insulin
secretion from pancreatic β-cells [7]. Recently, the presence of a
functional GIPR has been evidenced at the surface of osteoblasts
and osteoclasts [8,9]. However, the role of GIP in bone physiology
remains unclear. In vitro, it seems that GIP stimulates the synthesis
of collagen type I and TGF-β by osteoblasts [10,11]. However, the
possible role that GIP might have in controlling bone resorption
and/or bone remodeling in vivo is more controversial. Indeed, although
Zhong et al., reported that GIP directly reduced osteoclast activity in
mature murine osteoclasts in vitro [12], Tsukiyama et al. observed no
direct effects of GIP on the same cells [13]. By using a model of
GIPR-deﬁcient mice, Tsukiyama et al. described a decrease in trabecular
thickness at 8 weeks of age, but this decrease was not observed in
6-week-old animals. Furthermore, 6 week-old GIPR-deﬁcient mice did
not present with a reduction of the trabecular bone volume. However,
the number of osteoclasts was augmented at both ages [13]. On the
other hand, using the same GIPR-deﬁcient model, Xie et al. described
a reduction in trabecular bone volume in younger animals (4-week-old)
[14]. This reduction in BV/TV was accompanied by an increase in
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duction in trabecular separation [14]. These authors also reported a re-
duction in bone mineral content in older animals (3- and 5-month old)
[14]. From these two studies, the overall conclusion is that the lack of
GIPR signaling leads to a decrease, signiﬁcant or not, in bone mass.
More intriguing is the phenotype of GIP-overexpressing mice. In these
mice, GIP expression is under the control of a metallothionein promoter
and as such the supplementation in zinc led to high circulating GIP levels
[15]. Although one could expect a high bone mass, induction of GIP
over-expression led to a low bonemass phenotypewith a drop in trabec-
ular number [15]. These results support a negative regulation of bone
mass under GIP stimulation.
The aims of the present study were to conduct a comprehensive
investigation of trabecular bone mass and microarchitecture in GIPR
knockout male mice and to assess other parameters of quality of the
trabecular bone matrix [16]. Our results indicated that 16-week-old
GIPR-deﬁcient male mice present with a signiﬁcant increase in BV/TV,
associated with an increase in trabecular number and a decrease in
osteoclast number. Bone quality of the trabecular bone matrix was
also reduced in animals lacking a functional GIPR.Material and methods
Animals
Male and femalemice presenting a deletion of theGIPRwere used in
this study. The background and generation of GIPR-deﬁcient mice used
in this study has been previously described [17]. Age-matched wild-
type (WT) mice with the same C57BL/6 genetic background were
used as controls (Harlan Ltd., Oxon, UK). Animals were maintained on
a 12 h:12 h light–dark cycle in a temperature-controlled room
(21.5±1 °C). Animals were individually caged and received food and
water ad libitum. All experiments were conducted according to United
Kingdom Ofﬁce regulations (UK Animals Scientiﬁc Procedures Act
1986) and European Union laws. Animalswere injected intraperitoneally
with calcein (10 mg/kg) seven and two days before necropsy. Blood
samples were collected from the cut tip of the tail vein (~200 μl) of
consciousmice prior to sacriﬁce by lethal inhalationwith CO2 and tibias
were then harvested and processed as previously described [18].Body composition measurements
Lean and fat percentageweremeasured by dual energy X-ray absorp-
tiometry using a PIXImus system (Inside Outside Sales, Wisconsin,
U.S.A.). The PIXImus system allows accurate measurement of small
laboratory animals using a relatively lowX-ray energy and ultra high res-
olution (0.18×0.18 mm pixel size). Whole body weight was measured
after overnight fasting and the nose-to-tail length was determined.Intraperitoneal glucose tolerance tests
Drinking water and a standard rodent maintenance diet (Trouw
Nutrition, Cheshire, UK) were freely available until 18 h before test.
Mice received an intraperitoneal injection of glucose alone (18 mmol/kg
body weight) in a ﬁnal volume of 8 ml/kg body weight. Blood samples
were collected from the cut tip on the tail vein of conscious mice into
chilled ﬂuoride/heparin glucose microcentrifuge tubes (Sarstedt,
Nümbrecht, Germany) immediately prior to injection and at 15, 30 and
60 min post-injection. Plasma was aliquoted and stored at−20 °C prior
to glucose determination. Plasma glucose and insulin were assayed by
an automated glucose oxidase procedure using a Beckman Glucose
Analyzer II (Beckman Instruments, Galway, Ireland) and a modiﬁed
dextran-coated charcoal radioimmunoassay [19], respectively.X-ray microcomputed tomography
MicroCT analysis was performed with a Skyscan 1172 micro-
tomograph (Skyscan, Kontich, Belgium) equipped with an X-ray tube
working at 69 kV/100 μA. The pixel size was ﬁxed at 3.75 μm, the rota-
tion step at 0.25° and exposurewas donewith a 0.5-mmaluminum ﬁlter.
Bone mass and microarchitecture at the tibia metaphysis were deter-
mined with the CTan software (release 1.11.4.2, Skyscan). The volume
of interest (VOI) was located 0.5 mm below the growth plate on a
height of 2 mm (534 sections). Trabecular bone volume (BV/TV3D, in
%), trabecular thickness (Tb.Th3D, in μm), trabecular number (Tb.N, in
1/μm), trabecular separation (Tb.Sp, in μm), trabecular pattern factor
(Tb.Pf) and structure model index (SMI) were measured according to
guidelines and nomenclature proposed by the American Society for
Bone and Mineral Research [20].
Bone histomorphometry
Bone samples were embedded, undecalciﬁed in poly
(methylmethacrylate) (pMMA) at 4 °C to preserve enzyme activities.
Sections (7-μm thickness) were performed on a heavy duty microtome
equipped with a 50° tungsten carbide knife. For each animal, four non
serial sections (~50 μmapart) were left unstained for themeasurement
of calcein-based parameters (original magniﬁcation ×400), four sec-
tions were stained with Goldner's trichrome for two-dimensional
bone volume andmarrow adipositymeasurements (originalmagniﬁca-
tion ×40), four sections were stained with toluidine blue for osteoblast
counting (original magniﬁcation ×400) and four additional sections
were stained for the osteoclastic tartrate resistant acid phosphatase
(TRAcP). TRAcP identiﬁcation is based on a histoenzymatic detection
with a simultaneous azo-dye coupling method, bone being counter-
stained with phosphomolybdic aniline blue and was performed at an
original magniﬁcation of ×200 [21]. Only TRAcP-positive nucleated cells
in contact with bone were counted as osteoclasts. The region of interest
(ROI) was located in the secondary spongiosa 0.5 mm below the growth
plate on a height of 2 mm. Standard bone histomorphometrical nomen-
clatures, symbol and units were used as described in the report of the
American Society for Bone and Mineral Research [22].
Ex vivo cell culture
Bonemarrow cellswere isolated from the long bones of 16 weeks-old
male animals byﬂushing tibias and femurswith alpha-MEMaspreviously
reported [23]. For osteoblast differentiation, bone marrow cells were
plated into a 25 cm2 culture ﬂask until conﬂuency (~3 days). At
conﬂuency, cells were detached with trypsin 1% and seeded into a
24-well tissue plate at a density of 2.5×104 cells/well in alpha-MEM
supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml
penicillin, 100 μg/ml streptomycin, 5 mM β-glycerophosphate and
50 μg/ml ascorbic acid. For osteoclast culture, bone marrow cells were
cultured for 24 h into a 25 cm2 ﬂask in alpha-MEM supplemented
with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin and
100 μg/ml streptomycin to allow stromal cells attachment. Non adherent
cells were then collected and plated in 24 well-plate in alpha-MEM
supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml
penicillin, 100 μg/ml streptomycin, 25 ng/ml macrophage-colony stimu-
lating factor (M-CSF-R&D systems, Abingdon, UK) and 50 ng/ml soluble
RANKL (Peprotech Ltd, London, UK). After seven days of culture, TRAcP
staining was performed as previously described [24]. TRAcP-positive
cells with more than three nuclei were considered as osteoclasts.
Gene expression
Total RNA was extracted from osteoblast or osteoclast ex vivo cul-
tures using TriZol, reversed transcribed using iScript cDNA synthesis kit
(Bio-Rad) and ampliﬁed by real-time PCR using SYBR GREEN PCR
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Table 1. The expression level of each sample was normalized against
gapdhmRNA expression.
Serum levels of soluble mediators
Levels of adipokines were determined using the mouse adipokine
proﬁler array (R&D Systems Europe, Abingdon, UK) according to the
manufacturer recommendations. Image analysis with Image J 1.45 s
was performed to quantify the relative expression of the different me-
diators of the array. Serum levels of c-terminal telopeptide of collagen
type I (CTX-I) and osteocalcin were assessed with commercially avail-
able kit (Ratlaps®-Immunodiagnostic systems and mouse osteocalcin
kit-Immutopics, respectively). Serum vanillylmandelic acid was assayed
with a commercially-available kit (CusaBio Biotech, Wuhan, China)
according to the manufacturer recommendations.
Quantitative backscattered electron imaging (qBEI)
Quantitative backscattered electron imaging was employed to
determine the bone mineral density distribution (BMDD) according
to the methodology described by Roschger et al. [25]. Poly
(methylmethacrylate) blocks used for bone histomorphometry were
polished to a 1-μm ﬁnish with diamond particles, carbon-coated and
observed with a scanning electron microscope (EVO LS10, Carl Zeiss
Ltd, Nanterre, France) equipped with a ﬁve quadrant semi-conductor
backscattered electron detector. The microscope was operated at
20 keV with a probe current of 250 pA and a working distance of
15 mm. The backscattered signal was calibrated using pure carbon
(Z=6, mean gray level=25), pure aluminum (Z=13, mean gray
level=225) and pure silicon (Z=14,mean gray level=253) standards
(Micro-analysis Consultants Ltd, St Ives, UK). For these contrast/bright-
ness settings, the BSE gray level histogram was converted into weight
percentage of calcium as described in Roschger et al. Eventual changes
in brightness and contrast due to instrument instabilities were checked
bymonitoring the current probe and imaging the referencematerial (C,
Al and Si) every 15 min. The trabecular bone areas were imaged
0.5 mm below the growth plate at a 200× nominal magniﬁcation,
corresponding to a pixel size of 0.5 μm per pixel. The gray level distri-
bution of each image was analyzed with a lab-made routine using
Image J. Three variables were obtained from the bone mineral density
distribution: Capeak is the most frequently observed calcium concentra-
tion, Camean is the average calcium concentration and Cawidth is the
width of the histogram at half maximum of the peak.
Nanoindentation
Nanoindentation tests evaluated the intrinsic mechanical properties
of the bonematrix. As nanoindentation assesses volume of material at a
length scale less than that of individual microstructural features in
bone, this technique avoids confounding factors such as microstructure
and porosity that affect tissue properties at larger length scales. Tests
were performed on the same sample used for qBEI measurements.
Brieﬂy, mechanical tests included ﬁve indents positioned in trabeculae
in the secondary spongiosa with a NHT-TTX system (CSM, Peseux,
Switzerland) equipped with a Berkowitch diamond probe. The indents
were done up to a depth of 900 nm with a loading/unloading rate of
40 mN/min. At maximum load, a holding period of 15 s was applied
to avoid creeping of the bone material. Maximum load, indentation
modulus, hardness and dissipated energy were determined according
to Oliver and Pharr [26]. Brieﬂy, maximum load corresponds to the
load reached at maximum penetration. Indentation modulus is deﬁned
by the initial slope of the unloading section of the curve whereas hard-
ness is interpreted as the mean pressure the material can resist and is
calculated as the ratio of maximum load to contact area. Dissipatedenergy corresponds to the area delimited by the loading and unloading
curves.
Fourier transformed infrared microspectroscopy (FTIRM)
Sections of 4 μm thickness were cut dry on a heavy duty micro-
tome equipped with tungsten carbide knives (Leica Polycut S) and
sandwiched between BaF2 optical windows. Spectral analysis were
obtained on a Bruker Vertex 70 spectrometer (Brukers optics, Ettlingen,
Germany) interfaced with a Bruker Hyperion 3000 infraredmicroscope
equipped with a standard single element Mercury Cadmium Telluride
(MCT) detector. Infrared spectra were recorded at a resolution of
4 cm−1, with an average of 32 scans in transmissionmode. Background
spectral images were collected under identical conditions from the
same BaF2 windows at the beginning and end of each experiment to
ensure instrument stability. For FTIRM analysis, spectra were acquired
on three different trabeculae per section with an area of 45×45 μm
each and analyzed with the Opus Software (release 6.5, Bruker).
Four sections per animal were analyzed. Sequential raw spectra
for each trabecula were averaged and the contribution of the em-
bedding pMMA and water vapor were corrected prior to baseline
correction. The evaluated IR spectral parameters were (1) mineral
crystallinity, which reﬂects the apatite size and perfection, calculated as
the ratio of the relative intensity of subbands at 1020 and 1030 cm−1
of the phosphate band [27]; (2) collagen maturity, determined as
the relative ratio of pyridinium trivalent (Pyr, mature collagen)
to dehydrodihydroxylysinonorleucine divalent (deH-DHLNL, new
collagen) collagen cross-links using their respective subbands lo-
cated at 1660 cm−1 and 1690 cm−1 of the amide I peak [28] and
(3) carbonates to phosphates ratio, which reﬂects the carbonate
content in bone and determined by the ratio of integrated areas of
the υ2 CO32− region (850–890 cm−1) to the υ1, υ3 phosphate band
(900–1200 cm−1) [29].
Statistical analysis
Results were expressed as mean±standard error of the mean
(SEM). Non-parametric Mann–Whitney U-test was used to compare
the differences between the groups using the Systat statistical software
release 13.0 (Systat software Inc., San José, CA). Differences at pb0.05
were considered signiﬁcant. Correlation between serum levels of
adipokines and BV/TV3D was assessed by a least squares linear regres-
sion analysis.
Results
GIPR KO mice exhibit lower body mass and lower fat mass
The growth curve indicated that male GIPR-deﬁcient animals
presented at 16 weeks of age with a signiﬁcant 11% reduction in
body mass (p=0.027) (Fig. 1A). Furthermore, in terms of body compo-
sition, as compared with WT animals, GIPR deﬁcient mice at 16 weeks
of age presented with a signiﬁcant 27% decrease in fat mass (p=
0.027) (Fig. 1B). No differences in nose-to-tail lengthwere observed be-
tween WT and GIPR deﬁcient animals at 16 weeks of age (Fig. 1C). Al-
though blood glucose appeared slightly increased in GIPR deﬁcient
animals, no signiﬁcant differences were observed in this parameter
(Fig. 1D) nor in insulin levels (Fig. 1E).
GIPR KO mice have a higher trabecular bone volume
As body weight lag behind in 16 weeks old GIPR-deﬁcient animals,
trabecular bone volume was determined by high resolution microCT
at this age. As represented Fig. 2, the trabecular bone volume appeared
to be increased in male GIPR-deﬁcient animals. Indeed, as compared to
WT animals, male GIPR deﬁcient mice presented a signiﬁcant 20%
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Fig. 1.Morphometrical and body composition parameters in wild-type (WT) and GIPR knockout animals (GIPR KO). (A) Growth curve ofWT (white circles) and GIPR-deﬁcient mice
(black circles). (B) Fat content and (C) length of WT and GIPR-deﬁcient animals. (D) Blood glucose and (E) plasma insulin level in WT (white circles) and GIPR deﬁcient animals
(black circles). *: pb0.05 vs. WT. N=4–7 in each group.
224 C. Gaudin-Audrain et al. / Bone 53 (2013) 221–230increase in BV/TV3D (p=0.008; Table 1). This increase in trabecular
bone volume was accompanied by a signiﬁcant 17% augmentation in
trabecular numbers (p=0.006) and a 18% decrease in trabecular
separation (pb0.001) in GIPR KO animals. On the other hand, the
trabecular thickness was unchanged between WT and GIPR deﬁcient
animals (p=0.72). Although slight decreases in Tb.Pf and SMI were ob-
served, they did not reach signiﬁcance. In order to assess whether these
differences were gender-related, we also investigated the trabecular
microarchitecture in female GIPR-deﬁcient animals (Table 1). Here
again, deﬁcient animals presented with a signiﬁcant 40% augmentation
in BV/TV3D, associatedwith a 26% increase in Tb.N and a 14% decrease in
Tb.Sp (Table 1).
GIPR KO mice exhibit a decrease in osteoclast number and increase in
osteoblast activity
In order to conﬁrm the higher trabecular bone volume in GIPR
deﬁcient animals, we determined trabecular bone volume by
histomorphometry in male (Fig. 3) and female (Fig. 4). Again, wefound a 24% augmentation in trabecular bone volume in male
GIPR deﬁcient animals (p=0.038). The number of osteoclast per
bone perimeter was reduced in male GIPR deﬁcient animals by
20% (p=0.042). On the other hand, in GIPR deﬁcient animals, the num-
ber of osteoblasts was signiﬁcantly augmented and accompanied by
a signiﬁcant 80% increase in mineral apposition rate (Cn.MAR) and
a 440% augmentation in bone formation rate (Cn.BFR/BS) (1.7±0.3
vs. 3.0±0.4; p=0.018 and 0.29±0.02 vs. 1.56±0.69; p=0.021).
As compared with WT animals, serum levels of CTX were signiﬁcantly
reduced by 21.5% in male GIPR-deﬁcient animals (p=0.003). On the
other hand, despite an increase in serum osteocalcin in male GIPR-
deﬁcient animals, this parameter did not reach statistical signiﬁcance
(p=0.113). In female deﬁcient animals, the number of osteoclasts
was also signiﬁcantly decreased by 39% (p=0.021) and the number
of osteoblasts signiﬁcantly increased by 88% (p=0.025). Although no
differences were observed in Cn.MAR between female WT and
GIPR-deﬁcient mice, mineralized surface and bone formation rate
were increased signiﬁcantly by 55% (p=0.012) and 55% (p=0.019)
respectively.
Fig. 2. Three-D models of the tibia proximal metaphysis in wild-type (WT) and GIPR
knockout (GIPR KO) animals. Trabecular regions of interest have been colorized.
225C. Gaudin-Audrain et al. / Bone 53 (2013) 221–230Trabecular bone microarchitecture is also altered in old animals
As body weight is signiﬁcantly reduced in 16 weeks-old animals,
we determined trabecular microarchitecture parameters in younger
(8-weeks old) and older (45-weeks old)male animals. In young animals,
trabecular microarchitecture as assessed by high resolution microCT did
not seem affected by the lack of a functional GIPR (Table 2). However,
despite no alteration in the microarchitecture, the number of osteo-
clasts was signiﬁcantly reduced by 24% in these animals (p=0.025,
Supplemental Fig. S1). Also in these animals, as compared with WT
animals, the mineralized surface and bone formation rate were sig-
niﬁcantly increased (p=0.012 and p=0.009 respectively).Table 1
Trabecular microarchitecture in WT and GIPR KO mice at 16 weeks of age.
Male
WT
(n=11)
GIPR KO
(n=12)
BV/TV3D (%) 12.4±0.6 14.9±0.4⁎⁎
Tb.Th (μm) 55.3±1.4 54.7±0.6
Tb.N (1/mm) 2.3±0.1 2.7±0.1⁎⁎
Tb.Sp (μm) 268±5 220±5⁎⁎
Tb.Pf 0.0175±0.0006 0.0164±0.0011
SMI 1.72±0.04 1.66±0.08
⁎ pb0.05 vs. WT animals.
⁎⁎ pb0.01 vs. WT animals.In older animals, the trabecular alterations observed at 16 weeks of
age were exacerbated at 45 weeks of age (Table 2) in GIPR deﬁcient
animals as compared with WT. However, in these animals, despite a
decrease in the number of osteoclasts, this parameter did not reach
signiﬁcance (p=0.465). In the other hand, the number of osteoblasts
and marrow adiposity were signiﬁcantly increased (p=0.028 and
p=0.047 respectively) as compared with WT (Supplemental Fig. S2).
Osteoblast and osteoclast differentiation markers are affected in
GIPR-deﬁcient animals
In order to evaluate whether bone cell differentiation was impaired
in GIPR-deﬁcient mice, we performed ex vivo cultures of osteoclast and
osteoblast precursors (Fig. 5). Although the number of newly-generated
osteoclasts was reduced in ex vivo cultures of GIPR-deﬁcient mice, this
difference did not reach signiﬁcance (p=0.127). The number of alka-
line phosphatase positive cells and the extent of mineralization
were augmented in ex vivo cultures of GIPR-deﬁcient mice. However,
these two parameters also did not reach signiﬁcance (p=0.275 and
p=0.127, respectively). The gene expression proﬁle in osteoblast
cultures revealed signiﬁcant augmentations in runx2, osteocalcin
and collagen type I alpha I genes (p=0.05, p=0.05 and p=0.05
respectively). On the other hand, expression of atf4 and RANKL
genes was signiﬁcantly decreased (p=0.05 and p=0.05 respectively).
The gene expression pattern observed in osteoclast cultures revealed a
signiﬁcant decrease in nfat2, rank and trap gene expression (p=0.05,
p=0.05 and p=0.05 respectively).
Adipokine proﬁle is modiﬁed in GIPR-deﬁcient animals
As reported above, GIPR KO mice presented a reduction in fat
mass. As such, we aimed to determine the proﬁle of adipokines
known to affect bone remodeling. Serum levels of circulating leptin,
resistin and adiponectin were determined in male animals (Fig. 6).
Resistin levels were not signiﬁcantly different between GIPR KO and
WT animals (p=0.248). On the other hand, serum levels of leptin
were signiﬁcantly decreased (p=0.02) whilst adiponectin was signiﬁ-
cantly increased (p=0.043) in GIPR-deﬁcient animals as compared
with WT. A regression analysis between adipokine levels and BV/TV3D
was performed to estimate a possible role of adiponectin and leptin in
the observed skeletal phenotype. Serum adiponectin levels and trabecu-
lar bone volume were positively correlated with a correlation coefﬁcient
of 0.70 (p=0.043). Serum leptin levels and trabecular bone volumewere
inversely correlated with a correlation coefﬁcient of−0.72 (p=0.017).
As leptin has been shown to alter bone remodeling through a hy-
pothalamic relay and activation of the sympathetic nervous system,
we thought to determine the serum levels of vanillylmandelic acid
(VMA), a degradation products of catecholamine. Despite a decrease
in serum leptin level, the serum levels of VMA were reduced in
GIPR-deﬁcient animals as compared with WT but did not reachFemale
p value WT
(n=6)
GIPR KO
(n=5)
p value
0.008 4.5±0.3 6.3±0.6⁎ 0.021
0.72 60.9±1.5 64.4±2.0 0.386
0.006 0.7±0.1 1.0±0.1⁎ 0.043
b0.001 493±13 422±20⁎ 0.043
0.389 0.03±0.0017 0.02±0.001 0.248
0.559 2.42±0.1 2.39±0.04 0.773
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226 C. Gaudin-Audrain et al. / Bone 53 (2013) 221–230signiﬁcance (p=0.064, Fig. 6). We also thought to determine the ex-
pression of ucp2 in bone marrow. Ucp2 expression is tightly regulated
by the sympathetic nervous system. Here again, although ucp2 seemed
decreased in GIPR-deﬁcient animals, this parameter did not reach sig-
niﬁcance (p=0.275).
Intrinsic bone tissue quality is decreased in trabecular bone of GIPR KO
mice
The intrinsic mechanical properties of the trabecular network
were investigated by nanoindentation. Clearly, GIPR-deﬁcient animals
exhibited a reduction in intrinsic bone strength as evidenced by signif-
icant lower values for the maximum load, indentation modulus and
dissipated energy (Table 3). OnqBEI analysis, the bonemineral distribu-
tion in the trabecular bone tissuewas shifted to the left in GIPR KOmice
as compared to WT animals (Fig. 7), suggesting a lower mineralization
proﬁle in these animals. Indeed, Capeak was signiﬁcantly reduced
GIPR KO animals (23.11%±0.52 vs. 24.71%±0.42; p=0.028) (Table 3).
Furthermore, Camean was signiﬁcantly decreased in GIPR-deﬁcient ani-
mals (22.20%±0.88 vs. 23.78%±0.29; p=0.018). Although Cawidth was
slightly lower in deﬁcient animals, this parameter did not reach signiﬁ-
cance as compared with WT (2.88±0.21 vs. 3.45±0.49; p=0.078).Moreover, the Pyr/deH-DHLNL ratio was signiﬁcantly lower in GIPR-
deﬁcient animals as compared with wild type (Table 3). On the other
hand, no differences were observed neither in the crystallinity nor car-
bonate substitution of the mineral.
Discussion
Bone remodeling is a complex process subjected to regulation from
variousmolecules. The concept of control of bonemass and remodeling
by the gastro-intestinal tract has emerged in the last decade. Recently, a
role for gut-derived serotonin in the control of bone remodeling has
been evidenced [30,31] as well as a link between glucagon-like
peptide-2 and bone resorption [2]. In the present study, the role of
GIP, a gut peptide, in controlling bone mass and microarchitecture
was investigated. By using a model of GIPR deﬁciency, we evidenced a
signiﬁcant increase in trabecular bone volume associated with an
augmentation in trabecular number. This increase in trabecular
bone volumewas also accompanied by a reduction in the number of tra-
becular osteoclast and an increase in osteoblast activity as evidenced by
increased bone formation rate in male and female. At 45 weeks of age,
GIPR KO male mice presented with an extreme increase in trabecular
bone volume as compared with WT control mice. Ex vivo cultures of
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227C. Gaudin-Audrain et al. / Bone 53 (2013) 221–230WTandGIPRKObone cells highlighted that cell differentiationmight be
affected in deﬁcient animals. Indeed, although it did not reach signiﬁ-
cance, osteoclast precursors transformed into osteoclast at a lower
rate in deﬁcient animals whilst osteoblast differentiation seemed to in-
crease. The pattern of gene expression in these two cell population also
support these ﬁndings. Taken together, these results suggest a negative
effect of GIP/GIPR signaling on bone remodeling.
Previous studies performed by Xie et al. and Tsukiyama et al.
showed either a decrease of trabecular thickness or a decrease of tra-
becular bone volume in mice lacking a functional GIPR. It is worth
noting that these two studies, although performed on GIPR-deﬁcient
mice, have been undertaken with a different genetic construction. In
human, the gipr gene is composed of 14 exons whilst in rats and
mice, the gipr comprised 15 exons leading to several forms of this recep-
tor by alternative splicing [32]. The functional GIPR, independent of the
species, is a G protein-coupled receptor belonging to the B1 subfamily
which encompasses receptors for other hormones, including glucagon-
like peptide-1, vasoactive intestinal peptide, parathyroid hormone and
calcitonin [33]. Members of this family are composed of a large extracel-
lularN terminus, a serpentine domainwith seven transmembranehelices
and a short intracellular C terminus [34]. GIP interactswith its receptor by
binding to the extracellular domain. TheGIPRdeﬁcientmodel used byXie
et al. and Tsukiyama et al. possessed a deletion of exons 4 and 5 that
encode a portion, but not the totality, of the extracellular domain ofTable 2
Trabecular microarchitecture in male WT and GIPR KO mice at 8 weeks and 45 weeks of ag
8 weeks old
WT
(n=6)
GIPR KO
(n=6)
p va
BV/TV3D (%) 13.0±1.0 12.2±1.2 0.23
Tb.Th (μm) 52.7±2.2 50.8±1.0 0.24
Tb.N (1/mm) 2.6±0.2 2.3±0.2 0.36
Tb.Sp (μm) 226±9 260±21 0.16
Tb.Pf 0.0212±0.0016 0.0225±0.0006 0.46
SMI 1.95±0.08 2.00±0.04 0.57
⁎ pb0.05 vs. WT animals.
⁎⁎ pb0.01 vs. WT animals.the GIPR. Our model of GIPR deﬁciency consists of a deletion of the
ﬁrst 6 exons, which encode the totality of the extracellular domain
and a portion of the ﬁrst transmembrane helix of the GIPR [35,36].
Although both constructs resulted in non-functional receptors as
assessed by cAMP responses, one might argue that the binding afﬁnity
of GIP to its receptor might be different between the two constructs
and as such the availability of GIP for another splice variant of the recep-
tor might be impaired.
Surprisingly, the percentage of fat mass and the number of osteo-
clast were decreased in our GIPR-/-mice. This is in contradiction of
what was observed in previous studies were these two parameters
were increased [13,14]. Connections between fat and bone metabolism
have been evidenced, with a role for adipokines in controlling bone re-
modeling. Adiponectin controls bone formation through paracrine and
endocrine pathways [37]. Through a paracrine manner, adiponectin in-
creases osteogenesis whilst circulating levels of adiponectin have been
linked to indirectly enhancing insulin signaling in osteoblasts and as
such increasing bone formation. The mode of action of leptin, another
adipokine, on bone remodeling remains unclear. Most of the literature
supports the idea that leptin suppresses bone mass by acting in the
brainstem to reduce serotonin-dependent sympathetic signaling from
the ventromedial hypothalamus to bone. Osteoblasts appear to be a
target of this central regulation and lead to reduced bone formation
and increased expression of RANKL that promotes osteoclaste.
45 weeks old
lue WT
(n=6)
GIPR KO
(n=6)
p value
9 4.7±0.5 10.1±0.5⁎⁎ b0.001
3 62.9±1.7 69.7±1.6⁎ 0.018
8 0.8±0.1 1.5±0.1⁎⁎ b0.001
0 445±29 325±4⁎⁎ 0.004
9 0.0255±0.0007 0.0185±0.0009⁎⁎ b0.001
2 2.50±0.02 2.21±0.06⁎⁎ 0.001
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228 C. Gaudin-Audrain et al. / Bone 53 (2013) 221–230differentiation and bone resorption [38,39]. In our study, a relatively
strong correlation has been established between increased adiponectin
and reduced leptin levels, and increased trabecular bone volume indi-
cating that the modiﬁcations of adipokine proﬁle in GIPR-deﬁcient0
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Table 3
Bone quality analysis in male WT and GIPR KO mice at 16-weeks of age.
WT
(n=11)
GIPR KO
(n=12)
p value
Intrinsic tissue properties
Maximum load (mN) 15.3±0.6 13.9±0.1⁎ 0.027
Hardness (MPa) 889.1±39.7 822.4±12 0.074
Indentation modulus (GPa) 15.6±0.1 13.1±0.3⁎ 0.018
Dissipated energy (mN nm) 4189.9±60.8 3665.0±36.0⁎ 0.014
Bone mineralization parameters
Capeak (% weight) 24.7±0.4 23.1±0.5⁎ 0.028
Camean (% weight) 23.8±0.3 22.2±0.8⁎ 0.018
Cawidth 3.5±0.5 2.9±0.2 0.078
FTIRI parameters
Pyr/deH-DHLNL ratio 3.3±0.4 1.9±0.2⁎ 0.016
Mineral maturity 1.10±0.1 1.11±0.1 0.901
Carbonate substitution 0.006±0.001 0.006±0.000 0.934
⁎ pb0.05 vs WT animals.
229C. Gaudin-Audrain et al. / Bone 53 (2013) 221–230for leptin involvement in the observed skeletal phenotype. Further-
more, given the wide tissue-expression of the GIPR, an indirect effect
via other tissues cannot be excluded.
As regard with the incretin effects of GIP, although, we did not
perform oral glucose tolerance test to assess insulin response in this
condition, studies performed on the same GIPR KO model that we
used revealed that these animals are hypoinsulinemic in response to
oral glucose challenge with a 40% reduction in plasma insulin level
[17]. Insulin-deﬁcient mice present a growth retardation that occurred
predominantly in the fetal life with a decrease in bone formation [40].
Mice lacking the insulin receptor in osteoblasts have reduced bone
acquisition due to decreased bone formation and deﬁcient numbers of
osteoblasts [41]. As such it is intriguing why animals with a lower insu-
lin response do not present a similar bone phenotype. One reasonmight
reside in the serum level or tissue-sensitivity for GLP-1. Indeed, Pamir
and coworkers demonstrated in the other model of GIPR KO mice that
although these animals presented with a mild impairment in glucose
tolerance, the sensitivity of the pancreatic islet for GLP-1 was augment-
ed in deﬁcient animals as compared withWT controls [42]. In our study
we did not investigate the tissue sensitivity for GLP-1, but in regardwith
the anabolic effect of the GLP-1 pathway in bone [43], we cannot rule
out the involvement of this molecule in the observed bone phenotype.
The quality of the bonematrix was reduced inmice lacking the GIPR
receptor. Thus, the intrinsic properties of the bone matrix (hardness,
elasticity modulus, dissipated energy) were all reduced in deﬁcient
animals. One could wonder why the choice of nanoindentation has
been preferred to more classical biomechanical tests. Three-point
bending is almost exclusively performed at the midshaft femur or0
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Fig. 7. Bone mineral density distribution in male wild-type (WT) and GIPR knockout
(GIPR KO) animals at 16 weeks of age. Plain curve (GIPR KO) is shifted to the left as
compared to dotted curve (WT). N=11–12 in each group.tibia in mice. This location barely contains trabecular bone and as
such three-point bending evaluate the biomechanical response of
cortical bone not trabecular bone. Three-point bending is also highly
inﬂuenced by the bone piece geometry (cortical thickness, cortical
porosity, etc.…) and the biomechanical parameters obtained with
this methodology are a mix of geometry, microarchitecture and
material intrinsic quality. Vertebral axial compression could have
been an alternative to assess trabecular bone strength, but it is ex-
tremely challenging to dissect in mice only the vertebral bodies to
assess the response of trabecular bone. Here again, compression
tests are dependent of trabecular microarchitecture and material
intrinsic quality. As the aim of the studywas to investigate alsomaterial
intrinsic quality, we preferred to use nanoindentation. Nanoindentation
is a relatively newmethodology that allows investigation of biomechan-
ical parameters at a micro/nanoscopic level. As such, nanoindentation
data are not impacted by the confounding factors such as geometry or
microarchitecture and represent the intrinsic mechanical response of
the bone matrix. In our study, the bone matrix appeared to be signiﬁ-
cantly hypomineralized as evidenced from BMDD parameters and a de-
crease in collagen cross-links was also observed, supporting the idea
that in GIPR-deﬁcient animals, bone matrix is less mature. Despite an
apparent increase in trabecular bone volume, bone quality was deﬁnitely
reduced in these animals and the strength of trabecular bone might be
affected although it was not investigated in the present study.
In summary, deﬁciency in GIPR signaling in male mice led to a
higher trabecular bone volume associatedwith an increase in trabecular
number and a decrease in osteoclast numbers. These modiﬁcations of
the bone microarchitecture were associated with alterations of the
adipokine network. However, despite an apparent increase in bone
volume, quality of the bone matrix was reduced posing the problem
of bone strength. Further studies are required to understand the
overall mode of action of GIP on bone and to elucidate whether
targeting the GIP/GIPR pathway might represent a valuable alterna-
tive in bone therapeutics.
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